Figure 1. Schematic diagram of the setup for tissue imaging experiments. PC DAQ: Data acquisition. Mod i/p: Modulation input. QCL: Quantum cascade laser.
including the threshold gain, emitted power, lasing spectrum, and laser terminal voltage. 2 While optical feedback affects almost all laser parameters, the two we can most conveniently monitor are the emitted optical power and the voltage across the laser terminals. Of these, monitoring the laser terminal voltage is preferable as it obviates the need for an external terahertz detector. 3 The small voltage variation (referred to as the SM signal) depends on both the amplitude and phase of the electric field of the reflected laser beam. This results in a highly sensitive and compact sensing technique that can probe information about the complex reflectivity or refractive index of the external target.
We can create SM signals by exploiting temporal variations in optical length of the external cavity (through variation of its refractive index or the physical length), complex reflectivity of the target, or the laser frequency. The imaging process involves illuminating static objects with terahertz radiation. In other words, the objects being imaged are not changing during the signal acquisition. Therefore, we require some type of modulation to generate an SM signal. Here we opt for slow frequency modulation, 4 which results in an SM waveform imprinted with
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the complex refractive index of the target. The sensitivity of this scheme is discussed in detail elsewhere. 5 We performed tissue imaging experiments using porcine tissue and murine skin. We first acquired a 2D array of timedomain waveforms and then reduced each waveform to a corresponding array of numbers, forming an image. Figure 2 shows results of the reflection-mode imaging of a 3mm-diameter skin biopsy from the transgenic laboratory mouse strain Cdk4::Tyr-NRAS. 6, 7 The sample in Figure 2(a) shows a barely visible stage 1 melanoma lesion on the left hand side of the sample. Figure 2(b) shows a signal strength reduction of the terahertz waveforms, while Figure 2 (c) shows a corresponding phase reduction from the array of SM waveforms. We can relate the tumor plaque in this sample to features observable in the pair of terahertz image reductions.
In summary, we developed a highly sensitive and compact scheme that shows promise for biological imaging in the terahertz frequency range. Our approach offers the possibility of early detection of skin changes before they become apparent in visible images. Our results also point toward techniques for the characterization of healthy tissue types for the study of normal physiology and possible therapeutic approaches. Additionally, imaging of skin malignancy in animal models at terahertz wavelengths shows earlier and potentially more powerful discrimination than is currently possible in the visible and IR regions of the spectrum.
Continuous improvements in terahertz QCL technology will lead to devices operating at higher temperatures and consequently more robust and compact self-mixing instruments for tissue characterization. In future work, we will investigate the origin of contrast in biological tissues based on water content and distribution, and we will assess the innate molecular response at terahertz frequencies. A clearer understanding of these factors will guide us towards discriminating a variety of skin pathologies. 
